Haw Par Corporation Limited
Haw Par Corporation Limited (HAWPY) Stock Competitors & Peer Comparison
See (HAWPY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HAWPY | $28.64 | +0.00% | 1.6B | 14.25 | $2.01 | +4.28% |
| RHHBY | $39.41 | -0.05% | 256.8B | 21.85 | $1.80 | +3.47% |
| RHHVF | $314.98 | -0.56% | 252.8B | 21.51 | $14.57 | +3.47% |
| RHHBF | $332.39 | -0.18% | 252.8B | 23.05 | $14.42 | +3.31% |
| AZNCF | $150.29 | -0.02% | 233.1B | 28.30 | $5.31 | +2.15% |
| NVSEF | $112.44 | +0.95% | 213.4B | 16.39 | $6.86 | +3.52% |
| SNYNF | $92.79 | +0.25% | 113.2B | 16.03 | $5.79 | +4.72% |
| BMYMP | $785.00 | +0.00% | 90B | 3488.89 | $0.23 | +0.19% |
| CHGCF | $52.05 | +8.96% | 85.7B | 31.93 | $1.63 | +2.25% |
| CHGCY | $24.80 | -0.68% | 81.7B | 30.64 | $0.81 | +2.16% |
Stock Comparison
HAWPY vs RHHBY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, RHHBY has a market cap of 256.8B. Regarding current trading prices, HAWPY is priced at $28.64, while RHHBY trades at $39.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas RHHBY's P/E ratio is 21.85. In terms of profitability, HAWPY's ROE is +0.06%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, HAWPY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check RHHBY's competition here
HAWPY vs RHHVF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, RHHVF has a market cap of 252.8B. Regarding current trading prices, HAWPY is priced at $28.64, while RHHVF trades at $314.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas RHHVF's P/E ratio is 21.51. In terms of profitability, HAWPY's ROE is +0.06%, compared to RHHVF's ROE of +0.35%. Regarding short-term risk, HAWPY is more volatile compared to RHHVF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check RHHVF's competition here
HAWPY vs RHHBF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, RHHBF has a market cap of 252.8B. Regarding current trading prices, HAWPY is priced at $28.64, while RHHBF trades at $332.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas RHHBF's P/E ratio is 23.05. In terms of profitability, HAWPY's ROE is +0.06%, compared to RHHBF's ROE of +0.35%. Regarding short-term risk, HAWPY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check RHHBF's competition here
HAWPY vs AZNCF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, AZNCF has a market cap of 233.1B. Regarding current trading prices, HAWPY is priced at $28.64, while AZNCF trades at $150.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas AZNCF's P/E ratio is 28.30. In terms of profitability, HAWPY's ROE is +0.06%, compared to AZNCF's ROE of +0.19%. Regarding short-term risk, HAWPY is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check AZNCF's competition here
HAWPY vs NVSEF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, NVSEF has a market cap of 213.4B. Regarding current trading prices, HAWPY is priced at $28.64, while NVSEF trades at $112.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas NVSEF's P/E ratio is 16.39. In terms of profitability, HAWPY's ROE is +0.06%, compared to NVSEF's ROE of +0.31%. Regarding short-term risk, HAWPY is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check NVSEF's competition here
HAWPY vs SNYNF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, SNYNF has a market cap of 113.2B. Regarding current trading prices, HAWPY is priced at $28.64, while SNYNF trades at $92.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas SNYNF's P/E ratio is 16.03. In terms of profitability, HAWPY's ROE is +0.06%, compared to SNYNF's ROE of +0.10%. Regarding short-term risk, HAWPY is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check SNYNF's competition here
HAWPY vs BMYMP Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, BMYMP has a market cap of 90B. Regarding current trading prices, HAWPY is priced at $28.64, while BMYMP trades at $785.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas BMYMP's P/E ratio is 3488.89. In terms of profitability, HAWPY's ROE is +0.06%, compared to BMYMP's ROE of +0.32%. Regarding short-term risk, HAWPY is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check BMYMP's competition here
HAWPY vs CHGCF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, CHGCF has a market cap of 85.7B. Regarding current trading prices, HAWPY is priced at $28.64, while CHGCF trades at $52.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas CHGCF's P/E ratio is 31.93. In terms of profitability, HAWPY's ROE is +0.06%, compared to CHGCF's ROE of +0.17%. Regarding short-term risk, HAWPY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check CHGCF's competition here
HAWPY vs CHGCY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, CHGCY has a market cap of 81.7B. Regarding current trading prices, HAWPY is priced at $28.64, while CHGCY trades at $24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas CHGCY's P/E ratio is 30.64. In terms of profitability, HAWPY's ROE is +0.06%, compared to CHGCY's ROE of +0.17%. Regarding short-term risk, HAWPY is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check CHGCY's competition here
HAWPY vs GLAXF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, GLAXF has a market cap of 75.1B. Regarding current trading prices, HAWPY is priced at $28.64, while GLAXF trades at $18.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas GLAXF's P/E ratio is 16.91. In terms of profitability, HAWPY's ROE is +0.06%, compared to GLAXF's ROE of +0.22%. Regarding short-term risk, HAWPY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check GLAXF's competition here
HAWPY vs DSKYF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, DSKYF has a market cap of 47.1B. Regarding current trading prices, HAWPY is priced at $28.64, while DSKYF trades at $25.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas DSKYF's P/E ratio is 24.46. In terms of profitability, HAWPY's ROE is +0.06%, compared to DSKYF's ROE of +0.18%. Regarding short-term risk, HAWPY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check DSKYF's competition here
HAWPY vs DSNKY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, DSNKY has a market cap of 44.9B. Regarding current trading prices, HAWPY is priced at $28.64, while DSNKY trades at $24.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas DSNKY's P/E ratio is 23.20. In terms of profitability, HAWPY's ROE is +0.06%, compared to DSNKY's ROE of +0.18%. Regarding short-term risk, HAWPY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check DSNKY's competition here
HAWPY vs BAYRY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, BAYRY has a market cap of 31.3B. Regarding current trading prices, HAWPY is priced at $28.64, while BAYRY trades at $7.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas BAYRY's P/E ratio is -8.29. In terms of profitability, HAWPY's ROE is +0.06%, compared to BAYRY's ROE of -0.10%. Regarding short-term risk, HAWPY is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check BAYRY's competition here
HAWPY vs OTSKY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, OTSKY has a market cap of 26.4B. Regarding current trading prices, HAWPY is priced at $28.64, while OTSKY trades at $24.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas OTSKY's P/E ratio is 9.68. In terms of profitability, HAWPY's ROE is +0.06%, compared to OTSKY's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check OTSKY's competition here
HAWPY vs OTSKF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, OTSKF has a market cap of 23.4B. Regarding current trading prices, HAWPY is priced at $28.64, while OTSKF trades at $44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas OTSKF's P/E ratio is 8.60. In terms of profitability, HAWPY's ROE is +0.06%, compared to OTSKF's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check OTSKF's competition here
HAWPY vs ORINY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, ORINY has a market cap of 22.9B. Regarding current trading prices, HAWPY is priced at $28.64, while ORINY trades at $41.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas ORINY's P/E ratio is 26.94. In terms of profitability, HAWPY's ROE is +0.06%, compared to ORINY's ROE of +0.37%. Regarding short-term risk, HAWPY is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check ORINY's competition here
HAWPY vs ALPMY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, ALPMY has a market cap of 19.1B. Regarding current trading prices, HAWPY is priced at $28.64, while ALPMY trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas ALPMY's P/E ratio is 56.13. In terms of profitability, HAWPY's ROE is +0.06%, compared to ALPMY's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check ALPMY's competition here
HAWPY vs ALPMF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, ALPMF has a market cap of 18.7B. Regarding current trading prices, HAWPY is priced at $28.64, while ALPMF trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas ALPMF's P/E ratio is 55.05. In terms of profitability, HAWPY's ROE is +0.06%, compared to ALPMF's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check ALPMF's competition here
HAWPY vs GIKLY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, GIKLY has a market cap of 18.3B. Regarding current trading prices, HAWPY is priced at $28.64, while GIKLY trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas GIKLY's P/E ratio is 29.96. In terms of profitability, HAWPY's ROE is +0.06%, compared to GIKLY's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check GIKLY's competition here
HAWPY vs CSPCY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, CSPCY has a market cap of 14.9B. Regarding current trading prices, HAWPY is priced at $28.64, while CSPCY trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas CSPCY's P/E ratio is 24.52. In terms of profitability, HAWPY's ROE is +0.06%, compared to CSPCY's ROE of +0.18%. Regarding short-term risk, HAWPY is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check CSPCY's competition here
HAWPY vs CHJTF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, CHJTF has a market cap of 14.6B. Regarding current trading prices, HAWPY is priced at $28.64, while CHJTF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas CHJTF's P/E ratio is 25.50. In terms of profitability, HAWPY's ROE is +0.06%, compared to CHJTF's ROE of +0.18%. Regarding short-term risk, HAWPY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check CHJTF's competition here
HAWPY vs RCDTF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, RCDTF has a market cap of 13.5B. Regarding current trading prices, HAWPY is priced at $28.64, while RCDTF trades at $65.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas RCDTF's P/E ratio is 29.48. In terms of profitability, HAWPY's ROE is +0.06%, compared to RCDTF's ROE of +0.22%. Regarding short-term risk, HAWPY is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check RCDTF's competition here
HAWPY vs ORINF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, ORINF has a market cap of 11.4B. Regarding current trading prices, HAWPY is priced at $28.64, while ORINF trades at $81.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas ORINF's P/E ratio is 26.48. In terms of profitability, HAWPY's ROE is +0.06%, compared to ORINF's ROE of +0.37%. Regarding short-term risk, HAWPY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check ORINF's competition here
HAWPY vs GIFOF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, GIFOF has a market cap of 9.1B. Regarding current trading prices, HAWPY is priced at $28.64, while GIFOF trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas GIFOF's P/E ratio is 17.63. In terms of profitability, HAWPY's ROE is +0.06%, compared to GIFOF's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check GIFOF's competition here
HAWPY vs KYKOF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, KYKOF has a market cap of 9B. Regarding current trading prices, HAWPY is priced at $28.64, while KYKOF trades at $17.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas KYKOF's P/E ratio is 34.26. In terms of profitability, HAWPY's ROE is +0.06%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, HAWPY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check KYKOF's competition here
HAWPY vs GIFLF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, GIFLF has a market cap of 8.5B. Regarding current trading prices, HAWPY is priced at $28.64, while GIFLF trades at $13.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas GIFLF's P/E ratio is 27.80. In terms of profitability, HAWPY's ROE is +0.06%, compared to GIFLF's ROE of +0.03%. Regarding short-term risk, HAWPY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check GIFLF's competition here
HAWPY vs DPHAY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, HAWPY is priced at $28.64, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, HAWPY's ROE is +0.06%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, HAWPY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check DPHAY's competition here
HAWPY vs OPHLY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, OPHLY has a market cap of 5.3B. Regarding current trading prices, HAWPY is priced at $28.64, while OPHLY trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas OPHLY's P/E ratio is 15.75. In terms of profitability, HAWPY's ROE is +0.06%, compared to OPHLY's ROE of +0.06%. Regarding short-term risk, HAWPY is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check OPHLY's competition here
HAWPY vs OPHLF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, OPHLF has a market cap of 5.2B. Regarding current trading prices, HAWPY is priced at $28.64, while OPHLF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas OPHLF's P/E ratio is 15.63. In terms of profitability, HAWPY's ROE is +0.06%, compared to OPHLF's ROE of +0.06%. Regarding short-term risk, HAWPY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check OPHLF's competition here
HAWPY vs PTKFF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, PTKFF has a market cap of 4.5B. Regarding current trading prices, HAWPY is priced at $28.64, while PTKFF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas PTKFF's P/E ratio is N/A. In terms of profitability, HAWPY's ROE is +0.06%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, HAWPY is less volatile compared to PTKFF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check PTKFF's competition here
HAWPY vs SNPHF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, SNPHF has a market cap of 3.9B. Regarding current trading prices, HAWPY is priced at $28.64, while SNPHF trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas SNPHF's P/E ratio is 16.36. In terms of profitability, HAWPY's ROE is +0.06%, compared to SNPHF's ROE of +0.12%. Regarding short-term risk, HAWPY is less volatile compared to SNPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check SNPHF's competition here
HAWPY vs SNPHY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, SNPHY has a market cap of 3.8B. Regarding current trading prices, HAWPY is priced at $28.64, while SNPHY trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas SNPHY's P/E ratio is 16.23. In terms of profitability, HAWPY's ROE is +0.06%, compared to SNPHY's ROE of +0.12%. Regarding short-term risk, HAWPY is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check SNPHY's competition here
HAWPY vs VRBCF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, VRBCF has a market cap of 2.9B. Regarding current trading prices, HAWPY is priced at $28.64, while VRBCF trades at $346.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas VRBCF's P/E ratio is 17.21. In terms of profitability, HAWPY's ROE is +0.06%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, HAWPY is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check VRBCF's competition here
HAWPY vs HAWPF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, HAWPF has a market cap of 2.4B. Regarding current trading prices, HAWPY is priced at $28.64, while HAWPF trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas HAWPF's P/E ratio is 13.27. In terms of profitability, HAWPY's ROE is +0.06%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, HAWPY is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check HAWPF's competition here
HAWPY vs CMOPF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, CMOPF has a market cap of 1.2B. Regarding current trading prices, HAWPY is priced at $28.64, while CMOPF trades at $75.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas CMOPF's P/E ratio is 7.97. In terms of profitability, HAWPY's ROE is +0.06%, compared to CMOPF's ROE of +0.14%. Regarding short-term risk, HAWPY is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check CMOPF's competition here
HAWPY vs LYPHF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, LYPHF has a market cap of 1B. Regarding current trading prices, HAWPY is priced at $28.64, while LYPHF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas LYPHF's P/E ratio is 13.40. In terms of profitability, HAWPY's ROE is +0.06%, compared to LYPHF's ROE of +0.06%. Regarding short-term risk, HAWPY is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check LYPHF's competition here
HAWPY vs TGRNF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, TGRNF has a market cap of 790.8M. Regarding current trading prices, HAWPY is priced at $28.64, while TGRNF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas TGRNF's P/E ratio is 10.29. In terms of profitability, HAWPY's ROE is +0.06%, compared to TGRNF's ROE of +0.09%. Regarding short-term risk, HAWPY is less volatile compared to TGRNF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check TGRNF's competition here
HAWPY vs JCRRF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, JCRRF has a market cap of 609.3M. Regarding current trading prices, HAWPY is priced at $28.64, while JCRRF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas JCRRF's P/E ratio is -19.23. In terms of profitability, HAWPY's ROE is +0.06%, compared to JCRRF's ROE of -0.01%. Regarding short-term risk, HAWPY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check JCRRF's competition here
HAWPY vs MAYNF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, MAYNF has a market cap of 285.6M. Regarding current trading prices, HAWPY is priced at $28.64, while MAYNF trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas MAYNF's P/E ratio is -3.51. In terms of profitability, HAWPY's ROE is +0.06%, compared to MAYNF's ROE of -0.35%. Regarding short-term risk, HAWPY is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check MAYNF's competition here
HAWPY vs PTKFY Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, PTKFY has a market cap of 20.9M. Regarding current trading prices, HAWPY is priced at $28.64, while PTKFY trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas PTKFY's P/E ratio is 20.27. In terms of profitability, HAWPY's ROE is +0.06%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, HAWPY is less volatile compared to PTKFY. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check PTKFY's competition here
HAWPY vs PSYGF Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, PSYGF has a market cap of 1.8M. Regarding current trading prices, HAWPY is priced at $28.64, while PSYGF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas PSYGF's P/E ratio is -0.02. In terms of profitability, HAWPY's ROE is +0.06%, compared to PSYGF's ROE of +2.78%. Regarding short-term risk, HAWPY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for HAWPY.Check PSYGF's competition here
HAWPY vs CRXTQ Comparison August 2025
HAWPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HAWPY stands at 1.6B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, HAWPY is priced at $28.64, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HAWPY currently has a P/E ratio of 14.25, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, HAWPY's ROE is +0.06%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, HAWPY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for HAWPY.Check CRXTQ's competition here